Evaluation of “<i>Caterina assay</i>”: An Alternative Tool to the Commercialized Kits Used for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Identification

Evaluation of “<i>Caterina assay</i>”: An Alternative Tool to the Commercialized Kits Used for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Identification

Here we describe the first molecular test developed in the early stage of the pandemic to diagnose the first cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Sardinian patients in February–March 2020, when diagnostic certified methodology had not yet been adopted by...

Full description

Bibliographic Details
Main Authors: Germano Orrù, Alessandra Scano, Sara Fais, Miriam Loddo, Mauro Giovanni Carta, Giorgio Carlo Steri, Simonetta Santus, Riccardo Cappai, Maria Laura Ferrando, Ferdinando Coghe
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Pathogens
Subjects:
molecular diagnostic of SARS-CoV-2
COVID-19 detection
SYBR<sup>®</sup>Green real-time PCR
N protein
melting curve analysis
DNA folding
Online Access:https://www.mdpi.com/2076-0817/10/3/325

Internet

https://www.mdpi.com/2076-0817/10/3/325

Similar Items